1,3-Benzenedicarbonitrile, 2,4,5,6-tetra-9H-carbazol-9-yl-, 98%, 100mg

4,4,5,5-Tetramethyl-2-(4-(1,1,1-trifluoro-2-methylpropan-2-yl)phenyl)-1,3,2-dioxaborolane, 95.0%, 250mg

2-(Cyclobutanecarboxamido)-2-methylpropanoic acid, 95.0%, 1g

3-Bromo-4-nitro-1H-pyrazole, 95.0%, 250mg

1,3-DIMETHYL-1H-PYRAZOLO[3,4-B]PYRIDINE-5-CARBOXYLIC ACID, 95.0%, 250mg

2-Methylthiazole-4-carbonitrile, 95.0%, 250mg

Sodium hydroxide solution, ROTI®Volum 0.5 mol/l - 0.5 N, ampoule, 1 piece, plastic packaging.

2-Ethylphenyl Acetate>97.0%(GC)25g

2,3-Diaminobenzamide, 95.0%, 1g

9,9'-Spirobi[fluoren]-2-ylboronic acid, 95.0%, 100g

4-Benzyl N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-L-aspartate>98.0%(HPLC)(T)5g

N,N,2-Trimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide, 98%, 100g

Wide angle WF 15x/15 mm eyepiece, Ø 30 mm tube